Invention Grant
- Patent Title: Stimulation of NK cell activity by using a combination of broccoli, Nigella Sativa, Green Tea, and pterostilbene alone and together with metformin
-
Application No.: US17534292Application Date: 2021-11-23
-
Publication No.: US11951146B2Publication Date: 2024-04-09
- Inventor: Thomas Ichim , Timothy G. Dixon , Famela Ramos , Wais Kaihani
- Applicant: Therapeutic Solutions International, Inc.
- Applicant Address: US CA Oceanside
- Assignee: Therapeutic Solutions International, Inc.
- Current Assignee: Therapeutic Solutions International, Inc.
- Current Assignee Address: US CA Oceanside
- Agency: Baumgartner Patent Law
- Agent Marc Baumgartner
- Main IPC: A61K36/82
- IPC: A61K36/82 ; A61K31/09 ; A61K31/122 ; A61K31/155 ; A61K31/26 ; A61K31/352 ; A61K36/31 ; A61K36/45 ; A61K36/71 ; A61P31/14 ; A61P37/04

Abstract:
Disclosed are means, compounds, and compositions of matter useful for stimulation of natural killer cell activity. On one embodiment a composition termed QuadraMune™ comprised of pterostilbene, Nigella sativa extract, green tea extract, and broccoli. In some embodiments the invention teaches the administration of a therapeutic combination of ingredients comprising of metformin, pterostilbene, Nigella sativa, sulforaphane, and epigallocatechin-3-gallate (EGCG) to a mammal in need of natural killer cell immune modulation. In another embodiment, the invention teaches administration of said therapeutic combination to a mammal infected with said SARS-CoV-2. In some embodiments dosage of said therapeutic combination is based on inflammatory and/or immunological parameters observed in patients with COVID-19.
Public/Granted literature
- US20220160809A1 Stimulation of NK Cell Activity by QuadraMune Alone and together with Metformin Public/Granted day:2022-05-26
Information query